Dyne Therapeutics
DYN
#4676
Rank
โ‚ฌ1.57 B
Marketcap
15,49 โ‚ฌ
Share price
-31.15%
Change (1 day)
-1.98%
Change (1 year)

Dyne Therapeutics (DYN) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ0.70 Billion

According to Dyne Therapeutics's latest financial reports the company has โ‚ฌ0.70 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dyne Therapeutics - Cash on Hand chart (from 2019 to 2024)

20202021202220232024โ‚ฌ0.2Bโ‚ฌ0.4Bโ‚ฌ0.6Bโ‚ฌ0.8Bcompaniesmarketcap.com

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ0.11 B-53.34%
2022-12-31โ‚ฌ0.23 B-28.22%
2021-12-31โ‚ฌ0.33 B18.44%
2020-12-31โ‚ฌ0.28 B2049.39%
2019-12-31โ‚ฌ13.06 M83.93%
2018-12-31โ‚ฌ7.1 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ1.07 B 52.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.93 B 173.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ99.43 M-85.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.62 B-11.15%๐Ÿ‡บ๐Ÿ‡ธ USA